NCT04585100 - FM101 Safety, Tolerability, Efficacy Study in the Patients With Ocular Hypertension | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 7, 2020

Primary Completion Date

January 31, 2023

Study Completion Date

June 30, 2023

Conditions

Ocular Hypertension

Interventions

DRUG

FM101 tablet

Bio-equivalent test (tablet vs oral solution)

DRUG

FM101 oral solution

Bio-equivalent test (tablet vs oral solution)

DRUG

Placebo

Placebo BID for 28 days

DRUG

FM101 150 mg

FM101 (150 mg) BID for 28 days

DRUG

FM101 300 mg

FM101 (300 mg) BID for 28 days

Trial Locations (5)

RECRUITING

Norwest Eye Medical Pty Ltd, Bella Vista

RECRUITING

Adelaide Eye & Retina Centre, Adelaide

COMPLETED

CMAX Clinical Research Pty Ltd, Adelaide

RECRUITING

Eye Surgery Associates, East Melbourne

RECRUITING

Lions Eye Institute, Nedlands